×
About 9,996 results

ALLMedicine™ Viral Hepatitis Center

Research & Reviews  4,877 results

Pharmacotherapy options for managing hepatitis B in children.
https://doi.org/10.1080/14656566.2020.1841165
Expert Opinion on Pharmacotherapy; Komatsu H, Inui A et. al.

Oct 22nd, 2020 - To eliminate viral hepatitis by 2030, the World Health Organization (WHO) launched the first global health sector strategy on viral hepatitis, with particular focus given to hepatitis B and C in 2016. To achieve the reduction of mortality in child...

A Qualitative Community Assessment of Racial/Ethnic Sexual Gender Minority Young Adults...
https://doi.org/10.1177/1557988320966230
American Journal of Men's Health; Jeremiah R, Taylor B et. al.

Oct 21st, 2020 - HIV/STI, substance use, and mental health issues disproportionately affect racial/ethnic sexual minority young adults. These health vulnerabilities intensify across the life course, most notably when young adults are independent college students. ...

Women and barriers to harm reduction services: a literature review and initial findings...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574529
Harm Reduction Journal; Shirley-Beavan S, Roig A et. al.

Oct 20th, 2020 - There are an estimated 3.2 million women who inject drugs worldwide, constituting 20% of all people who inject drugs. The limited data that are available suggest that women who inject drugs are at greater risk of HIV and viral hepatitis acquisitio...

Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545399
World Journal of Gastroenterology; Aslan AT, Balaban HY

Oct 19th, 2020 - The hepatitis E virus (HEV) is the fifth known form of viral hepatitis and was first recognized as the cause of an epidemic of unexplained acute hepatitis in the early 1980s. Globally, it is one of the most frequent causes of acute viral hepatitis...

Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication us...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568415
BMC Gastroenterology; Sriphoosanaphan S, Thanapirom K et. al.

Oct 18th, 2020 - Vitamin D (VD) is important in hepatic fibrogenesis in animal models and human studies. VD deficiency is associated with liver fibrosis progression. Metabolic dysfunction of the liver, as an intermediate organ for VD metabolism, contributes partly...

see more →

Guidelines  13 results

HIV and Viral Hepatitis - CDC
https://www.cdc.gov/hiv/pdf/library/factsheets/hiv-viral-hepatitis.pdf

Jun 26th, 2019 - People with HIV infection are affected disproportionally by viral hepatitis. Nearly 75% of people with HIV who report a history of injection drug use also are infected with hepatitis C virus (HCV).

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries
https://journals.lww.com/ajg/pages/articleviewer.aspx?year=2017&issue=01000&article=00013&type=Fulltext
The American Journal of Gastroenterology; Kwo,P.,et al

Jun 30th, 2017 - Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests sh...

Joint Society statement for elimination of viral hepatitis.
https://doi.org/10.5604/16652681.1226808
Annals of Hepatology; Brahm J, Castera L et. al.

Jan 4th, 2017 - Joint Society statement for elimination of viral hepatitis.|2017|Brahm J,Castera L,Hou J,Lindor K,|standards,diagnosis,mortality,prevention & control,virology,standards,standards,standards,

2015 Sexually Transmitted Diseases Treatment Guidelines- Viral Hepatitis
https://www.cdc.gov/std/tg2015/hepatitis.htm

Jun 4th, 2015 - Hepatitis A, caused by infection with the hepatitis A virus (HAV), has an incubation period of approximately 28 days (range: 15–50 days) (819). HAV replicates in the liver and is shed in high concentrations in feces from 2–3 weeks before to 1 week.

Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted...
https://www.ncbi.nlm.nih.gov/pubmed/23135062
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports;

Nov 8th, 2012 - This report summarizes current (as of 2011) guidelines or recommendations published by multiple agencies of the U.S. Department of Health and Human Services (DHHS) for prevention and control of human immunodeficiency virus (HIV) infection, viral h...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  4,949 results

Pharmacotherapy options for managing hepatitis B in children.
https://doi.org/10.1080/14656566.2020.1841165
Expert Opinion on Pharmacotherapy; Komatsu H, Inui A et. al.

Oct 22nd, 2020 - To eliminate viral hepatitis by 2030, the World Health Organization (WHO) launched the first global health sector strategy on viral hepatitis, with particular focus given to hepatitis B and C in 2016. To achieve the reduction of mortality in child...

A Qualitative Community Assessment of Racial/Ethnic Sexual Gender Minority Young Adults...
https://doi.org/10.1177/1557988320966230
American Journal of Men's Health; Jeremiah R, Taylor B et. al.

Oct 21st, 2020 - HIV/STI, substance use, and mental health issues disproportionately affect racial/ethnic sexual minority young adults. These health vulnerabilities intensify across the life course, most notably when young adults are independent college students. ...

Women and barriers to harm reduction services: a literature review and initial findings...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574529
Harm Reduction Journal; Shirley-Beavan S, Roig A et. al.

Oct 20th, 2020 - There are an estimated 3.2 million women who inject drugs worldwide, constituting 20% of all people who inject drugs. The limited data that are available suggest that women who inject drugs are at greater risk of HIV and viral hepatitis acquisitio...

Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545399
World Journal of Gastroenterology; Aslan AT, Balaban HY

Oct 19th, 2020 - The hepatitis E virus (HEV) is the fifth known form of viral hepatitis and was first recognized as the cause of an epidemic of unexplained acute hepatitis in the early 1980s. Globally, it is one of the most frequent causes of acute viral hepatitis...

Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication us...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568415
BMC Gastroenterology; Sriphoosanaphan S, Thanapirom K et. al.

Oct 18th, 2020 - Vitamin D (VD) is important in hepatic fibrogenesis in animal models and human studies. VD deficiency is associated with liver fibrosis progression. Metabolic dysfunction of the liver, as an intermediate organ for VD metabolism, contributes partly...

see more →

News  137 results

Stick with the full 12-week DAA course for acute HCV
https://www.mdedge.com/gihepnews/article/219071/hepatitis/stick-full-12-week-daa-course-acute-hcv?channel=346
M. Alexander Otto, MDedge News

Mar 16th, 2020 - The first randomized trial to see if a short course of a direct-acting antiviral works as well for acute hepatitis C virus (HCV) infection as the standard 12-week course was stopped early after it became clear that it did not, according to a repor.

Liver cancer risk reduced by aspirin in chronic viral hepatitis
https://www.mdedge.com/gihepnews/article/219015/gastroenterology/liver-cancer-risk-reduced-aspirin-chronic-viral-hepatitis/page/0/1?channel=346

Mar 13th, 2020 - Limitations of the Study The current study findings are not new, but this is the best-designed study to date, commented Flemming. Still, there were a number of limitations, she noted.

Patients with viral hepatitis are living longer, increasing risk of extrahepatic mortality
https://www.mdedge.com/fedprac/article/207541/hepatology/patients-viral-hepatitis-are-living-longer-increasing-risk?channel=234
Will Pass

Sep 4th, 2019 - Patients with viral hepatitis may live longer after treatment with direct-acting antiviral agents (DAAs), but their risk of extrahepatic causes of death may rise as a result, according to investigators. Importantly, this increasing rate of extrahe.

Statins hamper hepatocellular carcinoma in viral hepatitis patients
https://www.mdedge.com/fedprac/article/206670/gastroenterology/statins-hamper-hepatocellular-carcinoma-viral-hepatitis?channel=234
Heidi Splete

Aug 19th, 2019 - Lipophilic statin therapy significantly reduced the incidence and mortality of hepatocellular carcinoma in adults with viral hepatitis, based on data from 16,668 patients. The mortality rates for hepatocellular carcinoma in the United States and E.

Lipophilic Statins Linked to Less Cancer in Viral Hepatitis
https://www.medpagetoday.com/cardiology/prevention/81682

Aug 19th, 2019 - Lipophilic statin use was linked to a significantly lower risk of both death and incident hepatocellular carcinoma (HCC) for people with hepatitis B or C virus infection in a Swedish cohort study. The 10-year HCC risk was 44% lower among people ta...

see more →

Patient Education  19 results see all →